{
    "2020-11-17": [
        [
            {
                "time": "2023-11-20",
                "original_text": "康泰生物：占总股本3.99%限售股将于11月20日上市流通 解禁",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "限售股",
                        "解禁",
                        "上市流通"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "康泰生物(300601.SZ)：约2727.27万股限售股11月20日解禁 解禁",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "限售股",
                        "解禁",
                        "股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "6429亿元，目标直指这些板块",
                "features": {
                    "keywords": [
                        "资金规模",
                        "目标板块"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股收盘综述：上证指数收跌0.21%，白酒股午后高台跳水",
                "features": {
                    "keywords": [
                        "A股",
                        "上证指数",
                        "白酒股",
                        "下跌"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股午盘综述：上证指数跌0.2%，创业板指跌2.55%",
                "features": {
                    "keywords": [
                        "A股",
                        "上证指数",
                        "创业板指",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业机遇和挑战并存，部分板块仍具备结构性机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "机遇",
                        "挑战",
                        "结构性机会"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}